Your treatment matters. Here’s why joining a diabetes clinical trial might be worth considering 2 April 2026 Paid partnership with Canopy Clinical Research Clinical trials are the reason most of today’s treatments exist. Trials help researchers discover better ways to prevent, manage, and treat conditions like diabetes, and they can also offer real benefits to participants. The first insulin trials in the 1920s transformed a once‑fatal diagnosis into a manageable condition. Later studies introduced metformin, and more recent trials paved the way for continuous glucose monitoring and insulin pumps. There are several reasons you might consider participating in a study. Why participate in a clinical trial? Access to enhanced monitoring and health assessments When you join a clinical trial, you are supported by a dedicated medical team who will follow your progress throughout the study. Clinical trials involve regular check-ins, health assessments, and opportunities to speak with the clinical research team about how you are managing your diabetes. New treatment options Clinical trials will often be exploring the effectiveness of new medications or devices that aren’t yet available to the public. For example, Canopy Clinical Research is currently conducting a study investigating a new medication for weight management in type 2 diabetes, as well as a diabetic foot ulcer trial which is investigating a new topical treatment designed to support healing. Your participation can help improve care for the wider diabetes community By taking part in a clinical trial, you can join a community of participants who are shaping history and the next generation of diabetes therapies. How to get involved? If you choose to register your interest in a clinical trial, the process usually begins with a brief pre‑screening call to discuss your health and diabetes history. This is followed by a clinic visit where you can meet the research team and ask any questions you may have. Learn more
Blog 23 August 2026 Spring clean your diabetes routine Now is the perfect time to dust off a few healthy habits, refresh your routine, and head into the warmer months feeling your best. Continue Reading
Media releases 19 August 2026 Wearable non-invasive continuous glucose monitor leads innovation challenge Xoma Labs has been named the Grand Innovation Challenge winner, following a nationwide search for innovative technologies to transform the lives of people living with diabetes. Continue Reading
Media releases 18 August 2026 500k Shane Warne Legacy Health Check milestone on the first day of international diabetes congress The Western-Pacific’s largest diabetes and metabolic health congress has opened with a Community Day in Melbourne, delivering the 500,000th Shane Warne Legacy health check to highlight the importance of cardiometabolic health screenings, and the urgent nature of the type 2 diabetes epidemic facing the region. Continue Reading